Skip to main content
Back
Watch Compare

EXAGEN INC.

Data quality: 100%
XGN
Nasdaq Services Health Services
$3.09
▲ $0.01 (0.32%)
Mkt Cap: 74.32 M
Price
$3.09
Mkt Cap
74.32 M
Day Range
$3.02 — $3.19
52-Week Range
$2.59 — $12.23
Volume
163,320
Open $3.08
50D / 200D Avg
$3.37
8.25% below
50D / 200D Avg
$7.25
57.40% below

Quick Summary

Key Takeaways

Revenue grew 8.35% annually over 5 years — modest growth
Negative free cash flow of -14.27 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11.30%
Capital efficient — spends only 0.96% of revenue on capex

Growth

Revenue Growth (5Y)
8.35%
Above sector avg (3.99%)
Revenue (1Y)19.65%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-101.86%
Below sector avg (-15.95%)
ROIC-22.59%
Net Margin-29.97%
Op. Margin-21.13%

Safety

Debt / Equity
1.26
Above sector avg (0.39)
Current Ratio4.08
Interest Coverage-3.26

Valuation

PE (TTM)
-3.73
Below sector avg (-1.17)
P/B Ratio4.10
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -3.7 -1.2
P/B 4.1 1.4
ROE % -101.9 -16.0
Net Margin % -30.0 -19.4
Rev Growth 5Y % 8.4 4.0
D/E 1.3 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) 19.65% Revenue Growth (3Y) 12.56%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 8.35% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 66.58 M Net Income (TTM) -19.95 M
ROE -101.86% ROA -32.82%
Gross Margin 58.28% Operating Margin -21.13%
Net Margin -29.97% Free Cash Flow (TTM) -14.27 M
ROIC -22.59% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.26 Current Ratio 4.08
Interest Coverage -3.26 Asset Turnover 1.10
Working Capital 39.70 M Tangible Book Value 18.14 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.73 Forward P/E N/A
P/B Ratio 4.10 P/S Ratio 1.12
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19.19%
Market Cap 74.32 M Enterprise Value 61.61 M
Per Share
EPS (Diluted TTM) -0.93 Revenue / Share 2.77
FCF / Share -0.59 OCF / Share -0.57
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.96% FCF Conversion 71.51%
SBC-Adj. FCF -15.94 M Growth Momentum 11.30

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 66.58 M 55.64 M 52.55 M 45.56 M 48.30 M
Net Income -19.95 M -15.12 M -23.69 M -47.39 M -26.85 M
EPS (Diluted) -0.93 -0.83 -1.34 -2.77 -1.68
Gross Profit 38.80 M 33.11 M — — —
Operating Income -14.07 M -13.64 M -22.84 M -46.05 M -24.07 M
EBITDA — — — — —
R&D Expenses 6.25 M 5.38 M 4.87 M 9.88 M 7.24 M
SG&A Expenses 46.62 M 41.37 M 47.43 M 52.02 M 44.54 M
D&A 2.10 M 1.70 M 2.20 M 1.60 M 900,000.0
Interest Expense 4.32 M 2.23 M 2.34 M 2.45 M 2.63 M
Income Tax 51,000.0 12,000.0 33,000.0 -282,000.0 175,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 58.02 M 44.69 M 56.94 M 86.22 M 123.45 M
Total Liabilities 40.57 M 35.15 M 34.25 M 43.76 M 38.51 M
Shareholders' Equity 17.45 M 9.54 M 22.69 M 42.46 M 84.94 M
Total Debt 22.91 M 20.25 M 19.50 M 28.97 M 27.48 M
Cash & Equivalents 32.22 M 22.04 M 36.49 M 62.39 M 99.44 M
Current Assets 48.89 M 36.46 M 47.84 M 72.61 M 112.73 M
Current Liabilities 14.16 M 13.51 M 11.90 M 9.62 M 9.32 M